The vast majority of thyroid cancers of follicular origin (TC) have a very favourable outcome,
but 5–10% of cases will develop metastatic disease. Around 60–70% of this subset, hence …

Most malignant thyroid tumours are initially treated with surgery or a combination of surgery
and radioactive iodine (RAI) therapy. However, in patients with metastatic disease, many …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Automatic lung disease detection is a critical challenging task for researchers because of the
noise signals getting included into creative signals amid the image capturing process which …

The development of the computer-aided detection system placed an important role in the
clinical analysis for making the decision about the human disease. Among the various …

Thyroid cancer is the most common endocrine malignancy. Most thyroid cancer types
respond well to conventional treatment consisting of surgery and radioactive iodine (RAI) …

Background Lenvatinib is a multi-kinase inhibitor approved for patients with radioactive
iodine (RAI)–resistant differentiated thyroid cancer (DTC). Before the drug approval from the …

Lung cancer poses a significant global public health challenge, emphasizing the importance
of early detection for improved patient outcomes. Recent advancements in deep learning …

In medical diagnostics, the invention of the computer-aided identification method has played
a significant role in making essential decisions for human diseases. Lung cancer requires a …

Background: Lenvatinib, an oral multikinase inhibitor, is the latest addition to the treatment
options for radioactive iodine (RAI)-refractory progressive differentiated thyroid carcinoma …